Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study

<p>Abstract</p> <p>Background</p> <p>Several different gene expression signatures have been proposed to predict response to therapy and clinical outcome in lung adenocarcinoma. Herein, we investigate if elements of published gene sets can be reproduced in a small datase...

Full description

Bibliographic Details
Main Authors: Passlick Bernward, Aumann Konrad, Wiech Thorsten, Kayser Gian, Feuerhake Friedrich, Neumann Jens, Fisch Paul, Werner Martin, zur Hausen Axel
Format: Article
Language:English
Published: BMC 2010-03-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/10/77
id doaj-3cf9acaa2195420db129570fee7cde27
record_format Article
spelling doaj-3cf9acaa2195420db129570fee7cde272020-11-24T21:15:43ZengBMCBMC Cancer1471-24072010-03-011017710.1186/1471-2407-10-77Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray studyPasslick BernwardAumann KonradWiech ThorstenKayser GianFeuerhake FriedrichNeumann JensFisch PaulWerner Martinzur Hausen Axel<p>Abstract</p> <p>Background</p> <p>Several different gene expression signatures have been proposed to predict response to therapy and clinical outcome in lung adenocarcinoma. Herein, we investigate if elements of published gene sets can be reproduced in a small dataset, and how gene expression profiles based on limited sample size relate to clinical parameters including histopathological grade and EGFR protein expression.</p> <p>Methods</p> <p>Affymetrix Human Genome U133A platform was used to obtain gene expression profiles of 28 pathologically and clinically annotated adenocarcinomas of the lung. EGFR status was determined by fluorescent in situ hybridization and immunohistochemistry.</p> <p>Results</p> <p>Using unsupervised clustering algorithms, the predominant gene expression signatures correlated with the histopathological grade but not with EGFR protein expression as detected by immunohistochemistry. In a supervised analysis, the signature of high grade tumors but not of EGFR overexpressing cases showed significant enrichment of gene sets reflecting MAPK activation and other potential signaling cascades downstream of EGFR. Out of four different previously published gene sets that had been linked to prognosis, three showed enrichment in the gene expression signature associated with favorable prognosis.</p> <p>Conclusions</p> <p>In this dataset, histopathological tumor grades but not EGFR status were associated with dominant gene expression signatures and gene set enrichment reflecting oncogenic pathway activation, suggesting that high immunohistochemistry EGFR scores may not necessarily be linked to downstream effects that cause major changes in gene expression patterns. Published gene sets showed association with patient survival; however, the small sample size of this study limited the options for a comprehensive validation of previously reported prognostic gene expression signatures.</p> http://www.biomedcentral.com/1471-2407/10/77
collection DOAJ
language English
format Article
sources DOAJ
author Passlick Bernward
Aumann Konrad
Wiech Thorsten
Kayser Gian
Feuerhake Friedrich
Neumann Jens
Fisch Paul
Werner Martin
zur Hausen Axel
spellingShingle Passlick Bernward
Aumann Konrad
Wiech Thorsten
Kayser Gian
Feuerhake Friedrich
Neumann Jens
Fisch Paul
Werner Martin
zur Hausen Axel
Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study
BMC Cancer
author_facet Passlick Bernward
Aumann Konrad
Wiech Thorsten
Kayser Gian
Feuerhake Friedrich
Neumann Jens
Fisch Paul
Werner Martin
zur Hausen Axel
author_sort Passlick Bernward
title Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study
title_short Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study
title_full Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study
title_fullStr Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study
title_full_unstemmed Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study
title_sort gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to egf-r status: a microarray study
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2010-03-01
description <p>Abstract</p> <p>Background</p> <p>Several different gene expression signatures have been proposed to predict response to therapy and clinical outcome in lung adenocarcinoma. Herein, we investigate if elements of published gene sets can be reproduced in a small dataset, and how gene expression profiles based on limited sample size relate to clinical parameters including histopathological grade and EGFR protein expression.</p> <p>Methods</p> <p>Affymetrix Human Genome U133A platform was used to obtain gene expression profiles of 28 pathologically and clinically annotated adenocarcinomas of the lung. EGFR status was determined by fluorescent in situ hybridization and immunohistochemistry.</p> <p>Results</p> <p>Using unsupervised clustering algorithms, the predominant gene expression signatures correlated with the histopathological grade but not with EGFR protein expression as detected by immunohistochemistry. In a supervised analysis, the signature of high grade tumors but not of EGFR overexpressing cases showed significant enrichment of gene sets reflecting MAPK activation and other potential signaling cascades downstream of EGFR. Out of four different previously published gene sets that had been linked to prognosis, three showed enrichment in the gene expression signature associated with favorable prognosis.</p> <p>Conclusions</p> <p>In this dataset, histopathological tumor grades but not EGFR status were associated with dominant gene expression signatures and gene set enrichment reflecting oncogenic pathway activation, suggesting that high immunohistochemistry EGFR scores may not necessarily be linked to downstream effects that cause major changes in gene expression patterns. Published gene sets showed association with patient survival; however, the small sample size of this study limited the options for a comprehensive validation of previously reported prognostic gene expression signatures.</p>
url http://www.biomedcentral.com/1471-2407/10/77
work_keys_str_mv AT passlickbernward geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy
AT aumannkonrad geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy
AT wiechthorsten geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy
AT kaysergian geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy
AT feuerhakefriedrich geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy
AT neumannjens geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy
AT fischpaul geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy
AT wernermartin geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy
AT zurhausenaxel geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy
_version_ 1716744306757206016